Serum gamma-glutamyltransferase (y-GT, EC 2.3. 2.2.) is one of the most sensitive indices of liver disease. Elevated activities occur in all forms of hepatobiliary disease (Rosalki, 1975) , but are particularly related to obstructive hepatobiliary disease where alkaline phosphatase activities are also raised (Ideo and Dioguardi, 1970) . However, increased y-GT activity is also found in a variety of other diseases-for example, myocardial infarction (Hedworth-Whitty et al., 1967) ,neurological diseases (Ewen and Griffiths, 1973) , and renal disease (Zein and Discombe, 1970) ; it is not certain whether this represents release of y-GT from these organs, or whether it occurs as a result of inapparent hepatic damage (Rosalki, 1975) .
During studies into various methods for differentiation of the enzyme present in serum and urine, it was found that n-butanol was of value in distinguishing between increased y-GT activities which occurred in different diseases. Biochemistry, 1978, 15, 151-156 Butanol extraction of serum and urinary gamma-glutamyltransferase and its application in clinical diagnosis P. R. BECK From the Department of Biochemistry, Royal Infirmary, Glasgow G4 OSF SUMMARY Gamma-glutamyltransferase (I' -GT) activity was measured in serum and urine before and after extraction with n-butanol. Residual y-GT activity after extraction of normal serum with butanol was more than 75 %, whereas for normal urine the figure was less than 68 %. The loss of activity from urine was not affected by prior dialysis, and the stabilisation which resulted from adding bovine serum albumin at a concentration of 40 gil did not approach the residual activity with normal serum. In patients with a variety of renal diseases, residual y-GT activity in the urine after butanol extraction was inversely correlated with the creatinine clearance. Butanol extraction was performed on serum samples from 182 patients with a variety of diseases. Eighty-one per cent of patients with elevated y-GT activities caused by hepatobiliary disease had an increased loss of activity after butanol extraction. By contrast, only 34 % of patients with increased y-GT activities in whom there was no clinical or other biochemical evidence of hepatic disease, had increased loss of y-GT activity after butanol. The reasons for differences between urinary and serum y-GT in response to butanol, and the implications in interpreting serum y-GT activities are discussed. y-GT was assayed kinetically (Beck and Chaudhuri, 1976) at 410 om and 37°C using y-glutamyl-pnitroanilide as substrate (Boehringer Corporation, Lewes, Sussex) on an LKB reaction rate analyser (LKB Products, London) with an attached Hook and Tucker K40 diluter and sampler (Hook and Tucker, Croydon, Surrey).
Annals of Clinical
Bovine serum albumin was obtained from Armour Pharmaceuticals, Eastboume, Sussex.
Routine liver function tests included serum bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase (AP). They were assayed by standard methods (Technicon AA II for bilirubin; Boehringer kits for enzymes).
Creatinine was measured by the method of Hare (1950) using Lloyd's reagent, and creatinine clearances were corrected to 1·73 m 2 body surface area.
Serum samples were stored at 4°C and were assayed within one week.
The urine was either a fresh random sample (for experimental work) or from a 24-hour collection, stored at 4°C without preservative until it was assayed within one week. The urine was neither centrifuged nor dialysed before assay.
Reference values for serum y-GT in this study are 1-35 iu/l ; no sex difference was found. 151 
Results

100
Standard method for butanol extraction
Serum or urine (0'5 mI) was diluted with an equal volume of water in a ground-glass stoppered tube. It was found necessary to dilute the serum to lessen the massive protein precipitation, which otherwise prevented adequate separation of layers after butanol extraction. Urine was diluted to keep the method constant.
After 0·1 mI of diluted sample had been removed for y-GT assay, an equal volume of n-butanol was added to the remainder. The stoppered tube was shaken well, and was then mixed on a rotary mixer for 15 minutes (Fig. 1 ).
?:
hours against running tap-water) before butanol extraction had no effect on the loss of y-GT activity. After centrifugation (1400 x g for five minutes), 0'1 mI of the lower (aqueous) layer was taken for y-GT assay. This layer was sampled by the K40 within 30 minutes, since a slow decline in y-GT activity occurs after butanol extraction (Fig. 2) .
The y-GT activity of the extracted serum (urine) was expressed as a percentage of the activity of the diluted serum (urine) before extraction.
Dialysis
Visking-tubing dialysis of urine samples (for 3'5
Precision
Within-batch precision for butanol extraction was estimated by extracting a pooled abnormal serum (activity neat---{)9 iu/I) and a urine (activity neat-14'5 iu/I) 20 times with butanol. For the serum the mean activity remaining was 35'7 %, with a coefficient of variation (CV) of 6'5%. The corresponding figures for the urine were 34'0% and 7'5%.
Between-batch precision was estimated by extracting pooled serum and urine with butanol on successive days. Ten extractions of serum (neat activity---M'7 iu/I) gave a mean percentage of remaining activity of 67'9% with CV of 17'2%. Urine (neat activity-15'6 iu/I) was extracted eight times and gave values of 41·7% of remaining activity, with a CV of 16'0%.
Clinical studies
Normal ranges for butanol extraction were established on 32 sera and 29 samples of urine obtained from healthy laboratory workers. Residual activity in normal sera was more than 75 %in all except one ( Fig. 3) . Seventeen of the serum samples showed no ..
loss of activity after butanol extraction. By contrast, residual activity in normal urine samples ranged from o to 68 %. This loss from urine was not affected by dialysis, nor was it completely stabilised by adding albumin at a concentration found in normal serum. However, butanol extraction of 49 samples of urine from patients with a variety of renal diseases revealed a weak, but significant inverse correlation between percentage residual activity after extraction and creatinine clearance ( Fig. 4) . Serum samples, received by the laboratory for routine liver function tests, from 182 patients with a variety of dieases, were extracted with butanol. The samples were divided into four groups:
1. Those from patients with known hepatobiliary disease and in which total y-GT was elevated (82 sera) . 2. Those from patients with known hepatobiliary disease but with normal total y-GT (6 sera). 3. Those from patients in whom there was no clinical or biochemical evidence of hepatobiliary disease, but with increased total y-GT (38 sera). 4. Those from patients in whom there was no clinical or biochemical evidence of hepatobiliary disease and in whom total y-GT was normal (56 sera). The clinical diagnoses in each group are summarised in the Table, and the results of butanol extraction are illustrated in Fig. 5 .
In the sera of patients with hepatobiliary disease and raised total y-GT activity, 81 % had a reduced percentage of residual activity after butanol extraction compared with normal sera. Group 2 sera showed a similar change after butanol extraction: five of the six sera had residual activities of less than 75%.
These results contrasted with those for Group 3 where only 34 % of sera had an increased loss of activity after butanol extraction. The difference in percentage of the remaining activities between Groups 1 and 3 was highly significant (p < 0,001, using the Mann-Whitney test for comparing medians).
Group 4 reflected normal sera in their response
The results presented here clearly show that it is possible to distinguish between y-GT in normal serum and normal urine by means of butanol extraction. The difference in response to butanol between y-GT in serum and urine does not appear to be related to their different environments, since neither dialysis of urine nor addition of albumin at a concentration found in serum modified the response to that of serum. This implies that there are molecular differences between y-GT in normal serum, normal urine, and sera with increased y-GT activities. This is confirmed by studies on gel filtration using Sephadex G2oo. Three peaks are found in sera (Orlowski et al., 1965) : a particulate form eluted with the void volume, and peaks with molecular weights of approximately 200 000 and 90 000. In normal sera these peaks are of nearly equal size, whereas changes occur in disease states which may affect individual peaks specifically (Orlowski et al., 1965) . Urine contains only two peaks, a very large exclusion peak and a small peak eluted at an identical position to the third peak of serum. Studies have shown that the effect of butanol on y-GT activity is related specifically to the exclusion peak, and to its height (Beck, in preparation) in that the large exclusion peak present in normal urine is associated with a large loss of activity after butanol. In patients with chronic renal failure, the first peak tends to be smaller, and this is consistent with the lesser loss of activity after butanol which is associated with low creatinine clearances (Fig. 4) . Similarly, patients with hepatobiliary disease generally demonstrate an increased first peak on gel filtration (Orlowski et al., 1965; Beck, unpublished observations) . Morton (1950) was the first to use n-butanol for the delipidation of enzymes, but he also noted the presence of a protein precipitate. Gombos (1976) also described protein denaturation by organic solvents in extraction of membranes. However, studies using other enzymes have shown that they may be delipidated by organic solvents and that activity may either be retained (Price and Sammons, 1974) , or reactivation may take place by readdition of phospholipid (Vore et al., 1974; Ingelman-Sundberg, 1977) . It is not yet known whether the loss of y-GT activity which occurs with butanol is caused by denaturation or by delipidation, but Discussion to butanol: 88 % had more than 75 % residual activity, and most patients retained 100% of y-GT activity.
There was no relationship between total serum y-GT activity and the loss after butanol extraction.
preliminary work suggests that the latter is correct (Beck, in preparation) . The reason for exclusion of the first peak from Sephadex G200 may be owing to the presence of lipid, and could be related to the membrane-bound enzymes described as present in the circulation in cholestasis (De Broe et al., 1975). y-GT is a widely distributed enzyme but elevations of serum activity are often thought to result entirely from hepatic damage, whether clinically apparent or not (RosaIki, 1975; Ceriotti, 1976) . It has been suggested that the increased y-GT activity in myocardial infarction is caused by subclinical hepatic hypoxia (Betro et al., 1973; Connell, 1973) although others have proposed that tissue repair processes in the myocardium explain such increases (Ewen and Griffiths, 1971; Szczeklik et al., 1972) . Ravens et al. (1969) found very little y-GT in normal dog heart, but it increased after experimental coronary artery ligation. The studies reported here would seem at first sight to support the views of Ravens et al. (1969) , since there is a clear distinction in the response to butanol between increased y-GT activity in hepatobiliary disease and in uncomplicated myocardial infarction. However, two further comments should be made. Firstly, extraction of a wide variety of tissues with butanol gives similar results to that of urine, and this is as expected from their gel filtration patterns (Beck, in preparation) . Secondly, in myocardial infarction where alanine transaminase activity was also increased all had elevations of y-GT activity, although some patients had increased y-GT with normal ALT. There was no clinical evidence of hypoxia or congestion in these patients, and they were placed in the non-hepatobiliary disease group. So that, while different organ sources may explain the varying response of serum y-GT to butanol, it is possible that the liver is the source in both groups, but that the natures of the insult differs, resulting in release of different y-GT fractions. A similar suggestion has been made by Kuska and Kokot (1970) to explain the differences between electrophoretic patterns of y-GT in serum and hepatic tissue in patients with liver disease.
Despite difficulties in interpreting the meaning of the results shown here, there is a clear distinction between primary, or significant hepatobiliary disease, and other causes of elevated y-GT activities.
Although the distinction is not absolute (19 % 'false negatives' for the hepatic Groups 1 and 2, and 34 % 'false positives' for the non-hepatic Groups 3 and 4) closer examination of these 'false' results is rewarding. Two of the myocardial infarction patients in Group 3 with residual activities of 65 % and 73 % despite the absence of clinically apparent congestive cardiac failure none the less had x-ray evidence of pulmonary congestion. Nine other patients in Groups 3 and 4 and with decreased activity remaining after butanol had diseases in which hepatic involvement was a potential complication, albeit not demonstrated, polyarteritis (1), brucellosis (1), chronic bronchitis, with slightly elevated AST and bilirubin (1), acute pancreatitis (2), pulmonary tuberculosis on rifampicin (4). In Group 1, normal butanol extractions were found in a patient with an inactive cirrhosis and normal biochemistry and in three patients in the late convalescent phase of their illness (two after hepatitis, one after cholecystitis). In addition, three out of four patients with primary biliary cirrhosis had normal butanol extractions, and it is worth mentioning that in the patient who was the exception this diagnosis was not proved. It is obviously necessary to confirm these 'anomalous' findings in a larger series of patients with this diagnosis. Finally, in Group 2 the only 'false negative' result was in a man with an aortic graft in whom bilirubin was considerably elevated and AST was slightly so; it is possible that this represented a haemolytic, rather than a hepatocellular, jaundice.
Butanol extraction of serum y-GT is therefore a valuable technique for distinguishing hepatobiliary disease (even in the absence of increased total activity of the enzyme) from those causes of a raised y-GT in which other clinical or biochemical evidence of hepatic involvement is absent. It may also provide considerable information on the role of lipids in the function of y-GT. I am very grateful to Dr J. King for his advice and encouragement during the studies. As its title implies, this book covers a truly enormous field. It can necessarily do so only by covering each topic relatively superficially. Nevertheless, it does so extremely well for in addition to being informative it is also both readable and pleasantly presented. Ample useis made of first class diagrams, figures, and other aids to teaching-such as the use of topical 'inserts' containing snippets of information outside the mainstream of the text but intended to hold the interest and motivation of the student. The academic standard aimed at and achieved is A-level chemistry and beyond-up to and including first-year undergraduate biochemistry. In clinical biochemistry, therefore, it is particularly suitable for the diminishing number of trainees whose first degree was in a subject other than biochemistry, for medical laboratory technicians wishing to broaden their academic base, and for older chemical pathologists who have largely forgotten it. It is difficult for the present-day student of biochemistry to appreciate the excitement with which enzymologists greeted the first revelations of the three-dimensional structures of enzymes almost 13 years ago. The rapidly growing number of such structures that has subsequently been elucidated has confirmed and re-confirmed some of the hypotheses of classical enzymology, such as the existence of specialised binding sites on the enzyme molecule adapted to receive the substrate molecule. However, no single general principle has emerged from structural studies, which accounts for the remarkable enhancement of reaction rates characteristic of enzyme catalysis. A development that has taken place in parallel with studies of enzyme structure is that of methods of studying pre steady state kinetics, and results obtained with these methods have made considerable contributions to the understanding of the mechanisms of enzymic reactions. Professor Fersht's book is a synthesis of present knowledge derived from these two approaches.
The book begins with a brief summary of knowledge of the three-dimensional structure of enzymes and enzymesubstrate complexes. This is followed by an account of chemical catalysis, which serves as an introduction to enzyme kinetics and reaction mechanisms. Not surprisingly in view of the subject matter of the book, steady state kinetics are not dealt with in great detail, and more space is devoted to the scope and methods of pre steady state kinetics. The last part of the book deals with enzyme specificity and theories of enzyme catalysis, illustrated with examples. Perhaps the most interesting conclusion to emerge from this section of the book is that several factors, rather than a single factor, contribute to different extents to the overall enhancement of rate of reaction effected by particular enzymes.
Clearly, this book is aimed mainly at the specialist enzymologist with a particular interest in enzyme mechanisms. For those with a more general interest, it provides clear summaries of the present state of knowledge on structure and mechanism, together with indications of the experimental methods on which the results are based. The clinical enzymologist, whose preoccupation is with the selection of conditions for measuring reaction rates, will not unreasonably require other sources for the steady state kinetic treatments which he needs to enable him to deal satisfactorily with multi-substrate reactions.
